ClinicalTrials.Veeva

Menu

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

P

Paragonix Technologies

Status

Invitation-only

Conditions

Liver Transplant Disorder
Liver Transplant Rejection
Liver Dysfunction
Liver Diseases

Treatments

Device: LIVERguard

Study type

Observational

Funder types

Industry

Identifiers

NCT05082077
PGX-005

Details and patient eligibility

About

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

Full description

GUARDIAN-Liver is a post-market, observational registry of adult and pediatric liver transplant recipient patients whose donor liver was preserved and transported within the LIVERguard. The data is being collected retrospectively from medical records of patients already transplanted before the initiation of the registry and any new patients who meet the eligibility criteria.

About 1000 male and female subjects meeting the study inclusion and exclusion criteria will be enrolled into the study at about 20 clinical sites.

Candidates that fit the eligibility criteria and have had their donor liver transported with a Paragonix product or a standard of care method can be enrolled. The baseline characteristics and outcomes of the two groups will be compared.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Donor and donor liver matched to the recipient based upon institutional medical practice
  • Registered male or female primary liver transplant candidates

Exclusion criteria

  • Donor and donor liver that do not meet institutional clinical requirements for transplantation
  • Living donors
  • Pediatric recipients (under 18)

Trial design

1,000 participants in 2 patient groups

LIVERguard patient
Description:
Patients whose donor liver was transported with the LiverGuard device.
Treatment:
Device: LIVERguard
Standard Transport Patients
Description:
Patients whose donor liver was transported with a method other than the LiverGuard

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems